TY - JOUR T1 - Treatment of juxtapapillary melanomas. JF - British Journal of Ophthalmology JO - Br J Ophthalmol SP - 715 LP - 717 DO - 10.1136/bjo.75.12.715 VL - 75 IS - 12 AU - P K Lommatzsch AU - R Lommatzsch Y1 - 1991/12/01 UR - http://bjo.bmj.com/content/75/12/715.abstract N2 - Thirty nine patients suffering from juxtapapillary choroidal melanoma were treated with Ru-106/Rh-106 beta-ray plaques. The tumoricidal dose was 100 Gy at the apex of the tumour within 7-14 days. Additional photocoagulation was performed in 12 eyes. The irradiated eyes of three patients had to be enucleated, seven patients died, five of them (12.8%) from metastases. Thirty two (82%) patients are alive and 29 (74%) have a seeing eye. From the whole series 20 (51%) developed flat scars and 11 (29%) patients retained a visual acuity of 0.5-1.0. Radiogenic late complications with damage to the optic nerve and macula were the main causes of visual deterioration. ER -